Evidence map›Paper›PMID 41868652›Full record

ReviewFrontiers in allergy2026

The FOXA transcription factors in allergic airway disease and asthma.

Diana C Yánez, Ching-In Lau, Jasmine Rowell, Eden Zhang, Tessa Crompton

Abstract readReview
In one paragraph

Review in Frontiers in allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Diana C YánezUCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Ching-In LauUCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Jasmine RowellUCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Eden ZhangUCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Tessa CromptonUCL Great Ormond Street Institute of Child Health, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Forkhead box A (FOXA) transcription factors are pioneer factors that orchestrate diverse cellular and developmental processes. Within the respiratory system, FOXA1, FOXA2, and FOXA3 have emerged as modulators of pulmonary inflammation, with important implications for the pathogenesis of allergic asthma. In healthy lung and airways, FOXA1 and FOXA2 maintain epithelial integrity and promote ciliated cell development, thereby preserving homeostasis. FOXA2 additionally suppresses Th2 differentiation and goblet cell metaplasia and mucus overproduction. During allergic airway inflammation, FOXA2 expression is decreased and FOXA3 expression is induced by Th2 cytokines. Dysregulation of the FOXA regulatory network disrupts epithelial cell homeostasis and amplifies allergic inflammation, contributing to airway remodelling. Here we will review the potential mechanisms through which the FOXA family modulates airway inflammation, while also addressing gaps in current understanding, such as the context specific regulation of FOXA isoforms, their interplay with cytokine signalling pathways, and the translational relevance of these findings to therapeutic strategies in asthma.

Indexed as

allergic airway diseaseasthmaFOXAgoblet cellsT-cellsTh2tissue remodelling

Identifiers

PMID41868652
PMCPMC12999953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.